Bermuda hospital build results in Alpines 'substantial loss' - lessons to be learned

By Admin
Share
Just two years ago in 2012, Sir Robert McAlpines Holdings was soaring with the construction of Londons Olympic stadium. Recently, substantial losses in...

Just two years ago in 2012, Sir Robert McAlpine’s Holdings was soaring with the construction of London’s Olympic stadium. Recently, substantial losses in the company’s Bermuda hospital contract have taken the company on a sharp and steep downhill decline, as the company has deteriorated during this expensive project. 

Director Ian McAlpine said: “The performance of the Caribbean construction business has been severely impacted by the difficulties encountered on the King Edward VII redevelopment.”

Since October of 2013, Sir Robert’s portfolio has shown a net loss of $37.7 million for the year, dropping from total profit earnings of $19.2 million in 2012. In addition to these devastating numbers, operating profits also fell from $17.4 million to $40.2 million in overall loss for the year.

The Telegraph reports, “Directors say the ‘deterioration’ was due to having to provide financial support to the company’s Bermuda-registered joint venture, BCM McAlpine Limited, which is part of the consortium redeveloping Bermuda’s King Edward VII Memorial Hospital (KEMH). The £176m contract has suffered “severe problems with design and performance”, say the accounts, resulting in “substantial losses” that have been covered by a £50m provision from Sir Robert McAlpine Holdings.”

The hospital project is due for completion within the next two months, and is the result of a public-private partnership, or PPP, between Bermuda Hospitals Board and the Paget Health Services consortium.

 

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma